Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Retained Earnings (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Retained Earnings for 17 consecutive years, with $16.9 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 13.3% to $16.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.9 billion through Dec 2025, up 13.3% year-over-year, with the annual reading at $16.9 billion for FY2025, 13.3% up from the prior year.
  • Retained Earnings for Q4 2025 was $16.9 billion at Bristol Myers Squibb, down from $17.1 billion in the prior quarter.
  • The five-year high for Retained Earnings was $28.8 billion in Q4 2023, with the low at -$1.5 billion in Q1 2021.
  • Average Retained Earnings over 5 years is $12.8 billion, with a median of $16.1 billion recorded in 2024.
  • Peak annual rise in Retained Earnings hit 2345.59% in 2023, while the deepest fall reached 105.71% in 2023.
  • Over 5 years, Retained Earnings stood at -$1.3 billion in 2021, then dropped by 1.03% to -$1.3 billion in 2022, then surged by 2345.59% to $28.8 billion in 2023, then plummeted by 48.16% to $14.9 billion in 2024, then grew by 13.3% to $16.9 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $16.9 billion, $17.1 billion, and $16.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.